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inTRODUCTiOn
The Eustachian tube (ET) is a narrow canal that courses from the middle ear cavity to the naso-
pharynx, which opens to provide ventilation to the middle ear and to equalize middle ear and 
ambient pressures (1). In this article, we refer by “Eustachian tube dysfunction” only to obstructive 
ET dysfunction, i.e., failure to open and ventilate the middle ear, as opposed to patulous ET dysfunc-
tion, in which there is failure of ET closure. ET dysfunction is a common medical problem with an 
estimated incidence of 1% in the adult population and produces symptoms of aural fullness, otalgia, 
tinnitus, and hearing loss, often exacerbated or precipitated by atmospheric pressure changes (2, 
3). Upper airway inflammation (including allergic rhinitis and chronic rhinosinusitis) commonly 
precipitate (episodes of) obstructive ET dysfunction (1). Long-lasting ET dysfunction may also 
result in middle ear conditions such as serous otitis media, tympanic membrane (TM) retractions, 
and cholesteatoma (4).
LACK OF HiGH-QUALiTY EViDEnCE FOR BALLOOn DiLATiOn 
OF THE ET (BDET)
Apart from potential drug-based therapies mainly focusing on comprehensive treatment of chronic 
rhinosinusitis, BDET has been suggested as a safe and feasible treatment option in cases refractory 
to medical treatment (5). During this procedure under general anesthesia, a balloon is introduced 
transnasally in the cartilaginous portion of the ET and inflated to a 20-mm length and a 3-mm 
width to a pressure of 10 bar for 2 min. However, the experience on BDET—results only reported 
in case series—has not reached an adequate level of evidence to support widespread clinical use 
(6). Ideally, a randomized double-blinded placebo-controlled trial (RCT) should be performed to 
achieve the highest level of evidence. Although an RCT is the “gold standard” to assess the efficacy 
of any intervention, we believe it is ethically not justifiable to perform “sham surgery,” in which 
the patient would be anesthetized but no surgical act performed. Therefore, we suggest an alterna-
tive study design to investigate the effect of BDET and achieve a comparable level of evidence: the 
delayed-start study design.
DELAYED-START STUDY DESiGn
The prospective delayed-start study design includes blinded assessment moments at baseline, after 
phase 1, and after phase 2 (7). At baseline, patients would have to be evaluated and will be randomly 
FiGURE 1 | Delayed-start study design. Blinded assessment at T1 with subsequent randomization. One group will receive treatment (empty circle) shortly after 
T1 and will be evaluated again at T2 and T3. The dotted line suggests the potential improvement in Eustachian Tube Dysfunction Questionnaire (ETDQ-7) in this 
group. The other group will be put on a waiting list and reevaluated at T2. The solid line suggests that these patients have stable symptoms at T2. Shortly after T2 
they will receive treatment (empty circle). The latter group will be evaluated again at T3.
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assigned to either the group that will receive immediate treatment 
or a group with a waiting time for the treatment, generally 12 weeks 
(Figure 1). While one group will receive (immediate) treatment 
at the beginning of phase 1, another group will be assessed at the 
end of phase 1 without receiving any treatment. The latter group 
will then receive (late) treatment, while the first group will be 
reassessed twice (at the end of phase 1 and phase 2). Both groups 
will be reassessed after phase 2. Ideally at the end of phase 1, the 
assessment would demonstrate statistical significance between 
the treated group and the group that was not treated yet. At the 
end of phase 2 (when all patients are treated), this statistically 
significant difference would disappear. Intermediate measures 
could include repeated scoring by means of the Eustachian Tube 
Dysfunction Questionnaire (ETDQ-7).
MiniMAL ET OUTCOME MEASURES
There are a wide range of ET function tests including imped-
ance audiometry (8), otoscopy (9), endoscopic findings (10), 
Eustachian Tube Score (11), tympanometry (4, 12), Valsalva 
maneuver (9, 11, 12), and pure-tone audiometry, but none can be 
considered as a gold standard. The optimal assessment tool for ET 
dysfunction lies probably in a combination of objective clinical 
tests and patient-reported outcome measures (13, 14). At each 
time point, an identical set of outcome measures should be used. 
We would prefer to use a combination including tympanometry, 
tubomanometry, and the ability to perform Valsalva maneuver 
during otoscopy. The 7-item ETDQ-7 and the Eustachian 
Tube Score 7 (ETS-7) can be used as patient-reported outcome 
measures. However, none of the suggested diagnostic tools are 
uniformly able to determine the adequacy of tubal function.
Tympanometry
Tympanometry is one of the few tests for ET dysfunction in 
regular clinical use. Though the technique is fast and robust, 
it is limited by middle ear pressure that can vary considerably 
over the course of a few hours. Consequently, a single measure 
of middle ear pressure might not provide enough information on 
ET opening (15).
Tubomanometry
The use of tubomanometry in clinical practice is still limited. 
Initial research suggested that this test can detect ET dysfunc-
tion with a sensitivity of 49% and specificity of 93% for opening 
threshold measurements, and a sensitivity of 87% and specificity 
of 67% for latency measurements (13). Its main limitations are 
that it is time-consuming and has a significant inter-operator 
variability (16).
Otoscopy
During otoscopy features like middle ear effusion or TM retrac-
tion can be suggestive for ET dysfunction. However, it is an 
insensitive measure of physiological performance of the ET and 
should rather be considered as a complication of ET dysfunction. 
As an alternative, patients with an aerated middle ear can perform 
a Valsalva maneuver while the TM is being visualized. When the 
patient indicates a change in aural pressure or the TM moves dur-
ing the maneuver, it is suggestive for patency of the ET. However, 
up to one-third of healthy individuals fail this test (17).
The 7-item ETDQ-7
The ETDQ-7 is a disease-specific instrument for the assessment 
of symptoms related to obstructive ET dysfunction. It is the only 
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symptom score of ET dysfunction to have undergone validation 
studies (18–20). The ETDQ-7 cannot discriminate between 
patients with obstructive and patulous ET dysfunction. However, 
we believe it is a precise measure of symptoms in patients with 
obstructive ET dysfunction (19). A recent study by our group 
showed that this questionnaire is responsive to change in patients 
with baro-challenge-induced ET dysfunction who have under-
gone BDET (20).
The ETS-7
The ETS-7 has been reported as a promising diagnostic tool for 
obstructive ET dysfunction (21). An advantage of the ETS-7 is 
the inclusion of objective and subjective elements including 
tubomanometry, tympanometry, and objective Valsalva.
COnCLUSiOn AnD FUTURE DiRECTiOnS
Clinical research in patients with ET disorders still suffers from 
the lack of high-quality evidence. The health technology assess-
ment by Llewellyn et al. (6) identified the variability in inclusion 
criteria and unclear and variable definitions for ET dysfunction 
as one of the principal findings. Therefore, definitions and diag-
nostic criteria were suggested in the 2015 consensus statement 
by Schilder et al. (14), which provides a significant step toward 
the design of future (high-quality) trials. In this consensus 
statement, RCTs were suggested to study change after treatment 
and to improve the level of evidence. Indeed, ideally an RCT 
should be performed to achieve the highest level of evidence. 
Although the surgeon is not blinded to the treatment allocation, 
blinded investigators can help to establish outcome. The most 
important consideration, however, is the ethical issue related 
to “sham surgery,” in which the patient would be anesthetized 
but no surgical act to be performed, or only one side is treated 
in bilateral cases (14). For this reason, we suggest an alterna-
tive study design to investigate treatment effect and achieve 
a comparable level of evidence: the delayed-start study design 
(also called the randomized-start design) (7). Although this 
study design shows great promise and regulatory authorities 
have shown to support this approach, few clinical researchers 
are aware of it.
In our opinion, this study design can provide a high-quality 
alternative to RCTs without potential objections by ethics com-
mittees toward randomization of real surgery and sham surgery. 
The optimal test (i.e., validated for the condition) for studying 
serous otitis media would be tympanometry, and in case of baro-
challenge-induced ETD, tubomanometry and the ETDQ-7 are 
the evaluation methods.
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